Hagen Brett R (CIK 0001681782)

Latest company ownership

KLRS - Kalaris Therapeutics, Inc.
Role: Chief Accounting Officer
Shares held
1,925
Last filed at
Mar 27, 2025
Confidence Score
49.9
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 26, 2025 Mar 27, 2025 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 47.5 -907 -32.03% ✗ $8.1K
Feb 21, 2025 Feb 24, 2025 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 47.5 -96 -3.28% ✗ $967.3
Jan 23, 2025 Jan 27, 2025 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 47.5 -36 -1.21% ✗ $342.3
Jan 10, 2025 Jan 13, 2025 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 52.5 -332 -0.48% ✗ $146.1
Nov 19, 2024 Nov 20, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 50.0 -554 -0.80% ✗ $303.9
Nov 5, 2024 Nov 6, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 47.5 -1,655 -2.34% ✗ $1.4K
Oct 21, 2024 Oct 23, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 47.5 -965 -1.35% ✗ $746.3
Oct 3, 2024 Oct 4, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 52.5 -301 -0.42% ✗ $245.3
Aug 19, 2024 Aug 20, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 50.0 -544 -0.75% ✗ $413.2
Aug 5, 2024 Aug 7, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 47.5 -1,692 -2.28% ✗ $1.2K
Jul 19, 2024 Jul 23, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 47.5 -960 -1.28% ✗ $714.9
Jul 2, 2024 Jul 3, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 52.5 -304 -0.40% ✗ $218.9
May 17, 2024 May 21, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 50.0 -541 -0.71% ✗ $405.4
May 3, 2024 May 7, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 47.5 -1,597 -2.06% ✗ $1.3K
Apr 19, 2024 Apr 23, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 47.5 -953 -1.21% ✗ $715
Apr 2, 2024 Apr 4, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 52.5 -281 -0.36% ✗ $216.9
Feb 20, 2024 Feb 22, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 50.0 -494 -0.62% ✗ $343.4
Feb 8, 2024 Feb 9, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 27.5 -11,150 -12.32% ✗ $7.5K
Feb 5, 2024 Feb 6, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 47.5 -5,792 -6.02% ✗ $3.9K
Jan 23, 2024 Jan 25, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 50.0 -901 -0.93% ✗ $604.4
Jan 4, 2024 Jan 8, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 52.5 -310 -0.32% ✗ $198.1
Dec 27, 2023 Jan 2, 2024 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 26.3 -28,335 -22.52% ✗ $20.8K
Nov 17, 2023 Nov 21, 2023 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 52.5 -403 -0.32% ✗ $657.3
Oct 19, 2023 Oct 23, 2023 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 50.0 -715 -0.56% ✗ $1.1K
Oct 3, 2023 Oct 5, 2023 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 52.5 -222 -0.17% ✗ $438.7
Aug 17, 2023 Aug 21, 2023 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 47.5 -1,653 -1.28% ✗ $4.1K
Jul 19, 2023 Jul 21, 2023 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 50.0 -684 -0.53% ✗ $2.4K
Jun 9, 2023 Jun 13, 2023 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 41.3 -5,045 -3.75% ✓ $28.5K
Apr 19, 2023 Apr 21, 2023 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 50.0 -697 -0.52% ✗ $2.6K
Jan 19, 2023 Jan 23, 2023 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 46.3 -1,895 -2.50% ✓ $9.6K
Nov 10, 2022 Nov 14, 2022 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 15.0 -24,000 -24.02% ✓ $195.2K
Oct 20, 2022 Oct 26, 2022 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 52.5 -345 -0.30% ✗ $3.2K
Oct 19, 2022 Oct 24, 2022 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 25.0 -13,679 -12.04% ✓ $115.3K
Apr 20, 2022 Apr 22, 2022 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 52.5 -276 -0.34% ✗ $1.8K
Jan 20, 2022 Jan 24, 2022 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 46.3 -1,563 -2.41% ✗ $13.7K
Feb 22, 2021 Feb 23, 2021 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 48.8 -800 -1.22% ✓ $34.5K
Feb 18, 2021 Feb 19, 2021 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 48.8 -741 -1.12% ✓ $29.7K
Feb 16, 2021 Feb 18, 2021 Kalaris Therapeutics, Inc. Chief Accounting Officer Sell 32.5 -5,370 -7.49% ✓ $221.6K